Rchr
J-GLOBAL ID:201801017748354059   Update date: Nov. 24, 2018

Tetsuro Yoshimaru

Tetsuro Yoshimaru
Affiliation and department:
Research theme for competitive and other funds  (6):
  • 2017 - 2020 ミトコンドリアを介した活性酸素制御による乳癌のホルモン療法耐性機構の解明
  • 2014 - 2017 Therapeutic advances in BIG3-PHB2 inhibition targeting the cross-talk between estrogen and growth factors in breast cancer
  • 2013 - 2016 Drug development and biological function study of novel estrogen receptor activity modulator BIG3 protein
  • 2012 - 2013 次世代シークエンサーによる新規乳がん関連遺伝子の探索
  • 2009 - 2010 ミトコンドリア由来活性酸素を標的とした免疫難病治療の新戦略
Show all
Papers (41):
more...
MISC (2):
Lectures and oral presentations  (87):
  • Preparation of Microencapsulated Enzyme for Lowering Allergic Activity of Food.
    (1996)
  • Role of reactive oxygen species in the high affinity IgE receptor-mediated intracellular signaling to degranulation and mediator.
    (2001)
  • Silver nitrate activates mast cells: Distinctions from FcRI-induced activation.
    (2001)
  • --
    (第18回日本がん分子標的治療学会学術集会 2004)
  • Heavy metals activate mast cells by an oxidant-dependent mechanism: role of redox-sensitive noncapacitative calcium influx.
    (2004)
more...
Education (1):
  • 2000 - 九州大学 大学院農学研究科食糧化学工学専攻博士課程 修了
Awards (2):
  • 2014/11/17 - The Koraku Foundation The Koraku Foundation 三木康楽会 康楽賞
  • 2014/06/26 - The Japanese Association for Molecular Target Therapy of Cancer 第18回 日本がん分子標的治療学会 優秀演題賞 エストロゲン受容体制御分子BIG3を標的とした新規ER陽性乳がん治療法の創製
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page